These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 3455550
1. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda. Tsega E. Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550 [Abstract] [Full Text] [Related]
2. [Effect of chloroquine in porphyria cutanea tarda]. Herrero C, Muniesa A. Med Cutan Ibero Lat Am; 1980 Nov; 8(4-6):139-45. PubMed ID: 7024672 [Abstract] [Full Text] [Related]
3. [Treatment of porphyria cutanea tarda with intermittent chloroquine]. Raff M, Formanek I. Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150 [Abstract] [Full Text] [Related]
9. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda. Malina L, Chlumský J. Acta Derm Venereol; 1981 Sep 01; 61(4):346-50. PubMed ID: 6173993 [Abstract] [Full Text] [Related]
10. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine]. Seubert S, Seubert A, Stella AM, Guzman H, Batlle A. Z Hautkr; 1990 Mar 01; 65(3):223-5. PubMed ID: 2339575 [Abstract] [Full Text] [Related]
11. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda]. Krivosheev BN. Vestn Dermatol Venerol; 1981 Sep 01; (9):50-4. PubMed ID: 7029950 [No Abstract] [Full Text] [Related]
12. Hydroxychloroquine treatment of porphyria cutanea tarda. Malkinson FD, Levitt L. Arch Dermatol; 1980 Oct 01; 116(10):1147-50. PubMed ID: 7425660 [Abstract] [Full Text] [Related]
16. The liver in Ethiopians with porphyria cutanea tarda. Tsega E, Damtew B, Landells JW, Besrat A, Seyoum E. East Afr Med J; 1982 Oct 01; 59(10):682-8. PubMed ID: 7185559 [No Abstract] [Full Text] [Related]
17. [Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine]. Michel B, Guillot B, Guilhou JJ, Meynadier J. Ann Dermatol Venereol; 1983 Oct 01; 110(4):361-3. PubMed ID: 6625460 [No Abstract] [Full Text] [Related]
18. Immunological and biochemical findings in patients with porphyria cutanea tarda. Błaszczyk M, Daoud S, Chorzelski T, Jabłońska S, Sulej J. Arch Immunol Ther Exp (Warsz); 1981 Oct 01; 29(6):757-62. PubMed ID: 7349094 [Abstract] [Full Text] [Related]
19. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)]. Kordac V, Martásek P, Kaláb M, Semrádová M, Papezová R. Cas Lek Cesk; 1981 Oct 08; 120(40):1225-7. PubMed ID: 7344792 [No Abstract] [Full Text] [Related]
20. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987]. Doss MO. Z Hautkr; 1988 Apr 15; 63(4):282-9. PubMed ID: 3291437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]